We examined whether increased IL-21 levels in AD and MCI resulted in enhanced action of this cytokine on immune cells in the periphery by determining the expression of IL-21R on monocytes, T and B cells in the PBMCs of AD, MCI and HC via flow cytometry. The gene discussed is IL21; the disease is Alzheimer disease.